SCHEMBL13766535

SCHEMBL13766535

CCNC1CCCCNCC1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.61
GNAI3 P08754 4/20 0.47
GNAO1 P09471 4/20 0.47
GNAI1 P63096 4/20 0.47
EPHX1 P07099 3/20 0.42
RAD52 P43351 1/20 0.42
SOS1 Q07889 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.32
SIGMAR1 Q99720 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19121999 0.94 KCNH2 (0.63) KCNH2GNAI3GNAO1GNAI1EPHX1
SCHEMBL1198152 0.89
Hydrochloric Acid SCHEMBL6629106 0.87 KCNH2 (0.71) KCNH2GNAI3GNAO1GNAI1EPHX1
SCHEMBL18236742 0.83 KCNH2 (0.73) KCNH2GNAI3GNAO1GNAI1EPHX1
SCHEMBL18236734 0.83 KCNH2 (0.73) KCNH2GNAI3GNAO1GNAI1EPHX1
SCHEMBL5784976 0.83 KCNH2 (0.73) KCNH2GNAI3GNAO1GNAI1EPHX1
SCHEMBL465770 0.82
SCHEMBL22316957 0.79 KDM4E (0.48) KCNH2EPHX1DPP7KDM4EALDH1A1
SCHEMBL22790769 0.79 KDM4E (0.48) KCNH2EPHX1DPP7KDM4EALDH1A1
SCHEMBL22416728 0.79 KDM4E (0.48) KCNH2EPHX1DPP7KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557110-B2 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine TEIJIN PHARMA LIMITED (JP) 2009-07-07 US disclosed